Scrip is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EMD Chemicals Inc.

Division of Merck KGaA
www.emindustries.com

Latest From EMD Chemicals Inc.

Deal Watch: Merck KGAA Boosts Pharma Unit’s Reach And Capabilities With Sigma-Aldrich Buy

Acorda buys Civitas and its Parkinson’s candidate for $525 million, ending the latter’s intent to go public. Pharmacyclics and Servier unwind their 2009 agreement to co-develop oncology drug abexinostat.

BioPharmaceutical Deals

Merck KGaA Buys Sigma-Aldrich To Boost Lab Business, Expand Footprint

By buying U.S.-based Sigma-Aldrich, the German conglomerate hopes to bolster its Millipore lab business, by giving the biopharma technology, tools and service provider added depth and global reach.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • EM Industries
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Merck KGaA
  • Senior Management
  • Meiken Krebs, Pres. & CEO
  • Contact Info
  • EMD Chemicals Inc.
    Phone: (914) 592-4660
    7 Skyline Drive
    Hawthorne, NY 10532
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register